Japan vs Vietnam: Cause of death, by non-communicable diseases, ages 60+, male
Japan
85.3%
in 2021
Vietnam
84.1%
in 2021
Japan rank
14th
Vietnam rank
17th
Cause of death, by non-communicable diseases, ages 60+, male over time
- Japan
- Vietnam
How they compare
Japan currently reports 85.3% against 84.1% in Vietnam, a difference of 1.2%.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was Japan ahead.
Japan ranks 14th and Vietnam ranks 17th of 185 countries.
Across the 3 decades both report, Japan averaged higher in 1 and Vietnam in 2.
Head to head by decade
| Decade | Japan | Vietnam | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 81.1% | 80.1% | 1.0% | Japan |
| 2010s | 82.1% | 87.0% | 4.9% | Vietnam |
| 2020s | 85.3% | 86.4% | 1.1% | Vietnam |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 60+, male, Japan or Vietnam?
- Japan, at 85.3% against 84.1% in Vietnam as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 60+, male between Japan and Vietnam?
- 1.2%, with Japan ahead.
- How many years of comparable data are there for Japan and Vietnam?
- 6 years are reported by both, from 2000 to 2021.
- How do Japan and Vietnam rank globally for cause of death, by non-communicable diseases, ages 60+, male?
- Japan ranks 14th and Vietnam ranks 17th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 60+, male (% of total male deaths ages 60+). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 60+ due to non-communicable diseases divided by number of all male deaths ages 60+, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.